Ignite Creation Date:
2024-05-06 @ 1:52 AM
Last Modification Date:
2024-10-26 @ 11:11 AM
Study NCT ID:
NCT01929213
Status:
UNKNOWN
Last Update Posted:
2014-01-09
First Post:
2013-08-22
Brief Title:
Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Udenafil and Bosentan After Oral Administration
Sponsor:
Dong-A Pharmaceutical Co Ltd
Organization:
Dong-A ST Co Ltd
Study Overview
Official Title:
A Randomized Open-label Multiple Dose Three-treatment Three-period Six-sequence Williams Design to Investigate the Pharmacokinetic Drug Interaction Between Udenafil and Bosentan After Oral Administration in Healthy Volunteers
Status:
UNKNOWN
Status Verified Date:
2014-01
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is designed to investigate the pharmacokinetic drug interaction and safety after oral administration of UdenafilDA-8159 and Bosentan in healthy volunteers
Design Randomized open-label multiple-dose three-treatment three-period six-sequence Williams design
Investigational Product Udenafil Bosentan
Design Randomized open-label multiple-dose three-treatment three-period six-sequence Williams design
Investigational Product Udenafil Bosentan
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None